MS Brain Health February 2018 Newsletter

Epic 100 km walk to raise awareness of MS Brain Health 

Jodi Haartsen, MS nurse and founding member of the Australian MS Brain Health Community, will be walking 100 km to increase awareness of brain health in MS and raise money to fight poverty. Exercise is an important part of looking after your brain health, so Jodi and the team are leading by example.

MS research news

Could lifestyle factors affect the course of MS? 

According to a recent study, several modifiable lifestyle factors may increase the risk of relapse in the early stages of MS. Obesity, high hip circumference and high levels of triglycerides in the blood were all associated with an increased risk of relapse. The authors suggest that maintaining a healthy weight and improving the lipid profile could protect against relapses in MS. Read more

Efficacy of MS drugs is linked to age

Researchers have reviewed data from MS drug trials to investigate how well various disease-modifying therapies (DMTs) work in people of different ages. The study revealed that efficacy of DMTs decreased with advancing age. These findings suggest that delaying treatment could result in the MS drugs being less effective. Read more

Neurologists recommend early investigation when MS is suspected

How long does someone wait for a diagnostic workup to confirm MS in your country? In the global MS consensus research presented at ECTRIMS 2017, neurologists recommended that the MS team should complete a diagnostic workup for MS within 4 weeks of referral. The group considered that this was a standard that most clinics should be aiming to achieve. Tell us, is this your experience?

Each month we will continue to take a closer look at one of the global standards that has emerged from the consensus research.

Awareness event for hand and upper limb function in people with MS

Live music and displays of artwork by people with MS highlighted the value of upper limb function at the #ThinkHand awareness event last week.

Over 100 people attended the event at the Bankside Gallery in London, where speakers highlighted the need for regulators, such as the European Medicines Agency, to recognize the value in maintaining hand and upper limb function in people with MS. Read more

You can follow us on Twitter @MSBrainHealth to keep up with the latest news. Thank you for your continuing support! 

Gavin Giovannoni, MD
Professor of Neurology and Chair of the MS Brain Health Steering Committee

On behalf of the MS Brain Health Steering Committee: Gavin Giovannoni, Peer Baneke, Helmut Butzkueven, Jodi Haartsen, Jeremy Hobart, Gisela Kobelt, Christoph Thalheim, Tony Traboulsee, Tim Vollmer and Tjalf Ziemssen

Related content